MR-22

N/A

Report date: 2023/11/07 10:23:27
NME

Base Information

Drug NameMR-22
Drug Alias NameMR22MR-22
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSalt-inducible kinases inhibitors
TargetsSalt-inducible kinases
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGoethe University Frankfurt
China Registration ClassN/A

Develop Information

Active CompaniesGoethe University Frankfurt
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A